Dr Deepak Kaushal's Falsification of Data Raises Serious Questions About His Involvement With Pfizer's C19 Vax Efficacy Claims
Part 1 of the docuseries based on this report is out now:
Gates Funded Dr Deepak Kaushal Settles With HHS’s Office Of Research Integrity Over Falsifying Research Data
A rather remarkable story broke this week. Dr Deepak Kaushal, who oversees the Texas Biomedical Research Institute’s $40+ million Southwest Primate Research Center which according to Science “receives about $10 million in federal funding per year and houses about 2500 marmosets, baboons, and macaques,” was credibly accused of research misconduct by the US Office of Research Integrity. He settled.
According to his bio:
“Dr. Kaushal is principal investigator on 15 NIH-funded grants and is co-investigator of 9 other NIH grants. He is also funded by the Bill & Melinda Gates Foundation among other private granting organizations.”
Here’s his autobiography on ResearchGate:
The HHS’s Office of Research Integrity (ORI) put out a press release on August 8, 2022 that their investigation into Deepak Kaushal, Ph.D. of the Texas Biomedical Research Institute indicated that he had committed research misconduct, over and over again:
“ORI found that Respondent engaged in research misconduct by intentionally, knowingly, and/or recklessly falsifying and fabricating the experimental methodology to demonstrate results obtained under different experimental conditions that were included in the following one (1) published paper and two (2) grant applications submitted for PHS funds” (src)
The paper from February 2020 and 2 grant applications (in 2019 & 2020) all involved tuberculosis. On the Texas Biomedical Research Institute’s website they claim that Deepak “is recognized for having developed the macaque model of TB using the natural inhalation route of infection and a model of Mtb/HIV co-infection.” ORI’s list of Deepak’s alleged offenses is very lengthy. According to an article by Science, the investigation was sparked by a tip submitted by an anonymous whistleblower.
“Specifically, ORI found that Respondent knowingly, intentionally, or recklessly:”
To me the list of problems seem impossible to blame just on sloppiness or mistakes (though that would be a big enough story). I’m actually amazed that all of this was able to be unearthed and published. I wonder what other fraud/ mistakes will never be discovered.
Disturbingly, Deepak Kaushal & his SNPRC can still apply for more government grants & Deepak has not lost his job as Director of the $40+ million SNPRC for the egregious misconduct. Rather- the Office of Research Integrity and Deepak Kaushal entered a Voluntary Settlement Agreement whereby Deepak is subject to having his federally funded research supervised for a year.
A spokesperson for the Texas Biomedical Research Institute said in a statement:
“Dr. Kaushal is an outstanding and transformative SNPRC director and the misconduct finding is not directly related to, and does not impact, his administrative leadership functions.” -Lisa Cruz, VP of Communications (src)
His case might be settled but this story is just getting started.
The Redacted Mycobacterium Tuberculosis Treatment Study
Let’s start with a deep dive into the redacted study that got Dr Deepak Kaushal in trouble with the feds: NIH NCIB, Original NCIB Entry, American Journal of Respiratory and Critical Care Medicine
Some pretty big claims made in the ‘at a glance’ section at the top of the paper:
A big question is: were the huge issues mistakes or deliberate fraud? I find it very telling that in the paper they published after the study they tried to make a really big deal out of their positive results. Not exactly bashful or remorseful behavior between the research falsification and finally being caught.
The article was redacted on April 15, 2021 by the publishing journal, the American Journal of Respiratory and Critical Care Medicine. One big difference jumps out between the authors blocks in the post-redacted NCIB vs the American Journal of Respiratory and Critical Care Medicine article. On the NIH NCIB website, Deepak Kaushal’s name has been awkwardly removed:
Last is not least when it comes to the author block ordering. In fact, the last name listed is usually the principal investigator or project leader. Very interesting that HHS’s Office of Research Integrity blames Deepak Kaushal by name (and only him) and he has been awkwardly removed from the redacted article on the NIH website.
Let’s go through the paper and see what the the methods called for. The rhesus macaques were to be immunized at the University of Louisiana at Lafayette and then challenged in Dr Deepak Kaushal’s Southwest National Primate Research Centre in San Antonio, Texas.
The now redacted Tuberculosis treatment paper was funded by NIH grants U19AI111211, R01AI111943, R01AI123047, R01AI134240, P51OD011104, P51OD011133, K24AI058609 & K24AI114444 (though other projects were funded with these grants also). Here are the NIH funded projects I could find within these NIH grants with Deepak Kaushal as one of the principal investigators/ project leaders:
Gates Foundation Funding
In addition to being The Gates Foundation website lists 4 grants to the Texas Biomedical Research Institute for a total of $4.3 million:
https://www.gatesfoundation.org/about/committed-grants/2020/09/inv019155
https://www.gatesfoundation.org/about/committed-grants/2015/08/opp1130674
https://www.gatesfoundation.org/about/committed-grants/2014/10/opp1111654
https://www.gatesfoundation.org/about/committed-grants/2017/08/opp1172972
When Deepak Kaushal was appointed the Director of the SNPRC in January 2019, the National Primate Research Center (the parent organization which includes 7 of the types of primate research facilities) put out a press release with some interesting info:
So let’s include the Gates funding for Tulane University too: We see a lot of grants for projects under the umbrellas of Tuberculosis:
https://www.gatesfoundation.org/about/committed-grants/2016/05/opp1149211
https://www.gatesfoundation.org/about/committed-grants/2015/06/opp1126491
https://www.gatesfoundation.org/about/committed-grants/2019/11/inv003368
These 3 Tuberculosis grants to Tulane University total over $4 million.
Added all up these two institutions affiliated with Deepak Kaushal received $8,370,037 just from the aforementioned Gates Foundation grants of interest
Dr Deepak Kaushal & The Pfizer/BioNTech Vaccine’s Claimed “Safety and Efficacy”
Texas Biomedical Research Institute put out a very interesting press release back on April 27, 2021 about Deepak Kaushal’s involvement with testing the BNT162B2 vaccine called “Texas Biomed shares critical work in development of Pfizer COVID-19 vaccine”
The press release then talks about the paper published in Nature on February 1st 2021 called "Immunogenic BNT162b vaccines protect rhesus macaques from SARS-CoV-2" (BioRxiv Preprint, Preprint PDF)
“The rhesus macaques at the Southwest National Primate Research Center (SNPRC) at Texas Biomed were quickly validated as models for studying vaccines designed to protect humans against SARS-CoV-2, the virus that causes COVID-19. The Pfizer-BioNTech COVID-19 vaccine was tested in this model at the Institute and has now been given to millions of people around the world.”
"It feels great to have contributed to the development of this important vaccine," said Deepak Kaushal, Ph.D., Professor and the Director of the SNPRC. "This is one circumstance where we helped develop a vaccine within months of the emergence of this new disease. The vaccine has been shown to be highly effective in protecting against COVID-19. As long as everyone in the U.S. who can take a vaccine does so over the next few months, I think we could shut the door on this pandemic before more variants arise."
The study, like the one that just got him reprimanded by the feds, involved injecting drugs or placebos into rhesus macaques and then challenging the primates with a pathogen, this time a culture of supposed SARS-CoV-2
And here is the entry for the SNPRC under the Authors & Affiliations section:
The article also tells readers to address all correspondence and requests for reprints straight to Deepak Kaushal:
Pfizer’s Director for VRD Bacterial Vaccines, Isis Kanevsky, joined Texas Biomedical Research Institute for their “Global Health Symposium” press conference. In the livestream and corresponding Texas Biomedical Research Institute press release Dr Deepak Kaushal sings his own praises:
"It feels great to have contributed to the development of this important vaccine. This is one circumstance where we helped develop a vaccine within months of the emergence of this new disease. The vaccine has been shown to be highly effective in protecting against COVID-19. As long as everyone in the U.S. who can take a vaccine does so over the next few months, I think we could shut the door on this pandemic before more variants arise." -Deepak Kaushal
“We train for moments like these” -Deepak Kaushal
“It was the whole world, turning to science, regardless of the politics, turning to science and saying ‘bring it! Let’s see what you can do.’ And we all, all of the scientists said “OK, we’re going to pause everything and we’re going to do it. And we’re going to do it the best that we can because it’s for us”… This is the only path that me, as a biased scientist that works on vaccines saw in a fasion and a timeframe that investment made possible, that you’re right we couldn’t have done in a different way. It had to be a company that really had all the resources and colleagues to know how to make this happen and then get the approvals that we needed. It wasn’t just our research. It was everybody else’s research showing comparable data. Reinforcing the platform. Reinforcing the vaccines. Reinforcing the efficacy. That gave us the confidence that this is going to work in a way that our science is supporting and our data is showing that it can. ” -Isis Kanevsky (Pfizer)
“It’s not that we changed anything in how the vaccines were developed. It’s not that we changed the questions we asked, or how we answered them, or safety or the immunogenicity or the efficacy. It was just done faster… But it also showed us how important it is to do it quickly” -Isis Kanevsky (Pfizer)
“The key takehome message… in the development of these vaccines there were no corners that were cut. We just slept less and we worked much harder. And indeed, it was time for scientists to stand up and be counted. And we did.” -Deepak Kaushal
“As someone who works with tuberculosis and HIV it feels great to be vindicated that vaccines work and can work with 100% efficacy” -Deepak Kaushal (possibly related to the redacted falsified TB data?)
"We were given the resources that we really needed. And then just all of the colleagues. I mean from the ground up. It's easy to sit here and have a chat just two of us. But two of us was not what made this happen. There's just no way to even start to say how many people were on call at all times to make things, to move things, to be change agile. From from the caretakers, to the technicians, to the people in our labs, to the people at our families that had to put up with everything that we put them through. And then Pfizer really enabled us to do things quickly. It was very clear that time was of the essence. It was really important to us- as scientists we're competitive. I'm a competitive person I have been all my life whether it's to get grants, or to train the best students or to bring the best science and develop the best models." -Isis Kanevsky (Pfizer)
What does Isis Kanevsky mean by saying so many people involved were “change agile”? Maybe she’s referring to cooking the books, like appears to have happened multiple times based on the whistleblower testimonies of like Brook Jackson, Brianne Dressen, Maddie DeGaray & Augusto Roux. I wonder if Isis Kanevsky & Mary Campbell know each other?
And Brook Jackson is extremelly credible on this matter. Just listen to her bio:
I’ve been in the clinical research industry for almost 20 years now. I’ve worked at the site level. I’ve worked in site management organizations, clinical research organizations. In those 20 years I’ve gained a considerable amount of expertise and knowledge from my time as a research study coordinator through my time as a clinical trial manager, a regional director; I have been a director of operations for a site management organization. So I’ve been doing this for a very long time (interview)
The revalations of research falsification by the Director of SNPRC, Deepak Kaushal, a heavily Gates-funded doctor who gets to keep his job and continue applying for NIH funding is leading to me reading between the lines of all the other personalities here.
Take for instance the quote from the CEO of Texas Biomed in the same April 2021 press release:
I think it’s also important to note that the statements made by Deepak Kaushal, Isis Kanevsky & Lisa Cruz (VP of communication, Texas Biomed) to me seem to suggest foreknowledge that the vaccines would ultimately not be truly effective long term and would continue to be updated for virus mutations. Honestly, to me, the Texas Biomed team seem really excited about the prospect of doing additional trials for Pfizer and the money that brings into their facility.
How can they they say how successful and effective the vaccines are, but in contradictory fashion pivot to talk about boosters and how the vaccines won’t be long lasting (ie truly effective) unless everyone takes them right away. Could it be they’re conspiring towards an ultimate endgame of rollout of regular covid shots? That would explain a lot.
Here are just some example quotes juxtaposing the declared efficacy, and the need to update vaccines and boost repeatedly:
During his interview of Pfizer Director Isis Kanevsky, Deepak Kaushal kept asking aboutwhy Pfizer went with mRNA (4:24, 8:20, 14:40) to which finally Isis Kanevsky claimed the reasoning behind the decision is “above her paygrade” It sounded to me like maybe he was trying to score some more work for his SNPRC “testing” all the other mRNA vaccines and booster updates coming down the R&D pipeline?
“The RNA vaccine… is just a sequence, a viral sequence of the virus. And that also for the same reason enables us to manufacture it with much speed. It's a rapid development. It's ability to adapt quickly to the sequence of a given virus which is proving to be even more timely now that we see potential mutations within the SARS cov2 virus. And in light of that exact reason this mRNA vaccine platform also provides small- minimal risk to anti-vector neutralizing antibody responses. So in other words: We can boost people. We can provide subsequent boosts to the vaccine as the virus changes to ensure that we keep everyone safe and healthy and control the virus in the future.” -Isis Kanevsky (Pfizer)
“It also enabled us to understand how important it is to be able to do it quickly right and how again this platform really stood up to the test and proved the scientists who developed it to be correct that it's very, very versatile and pivotal to be able to make something change and adjust to what a virus can do. And viruses are pretty impressive when they want to change and do things they're- as you can see- it can be pretty scary” -Isis Kanevsky (Pfizer)
Yet somehow, just seconds later she attributes “high efficacy” to the vaccine.
One other quote from Deepak Kaushal really jumps out from Texas Biomedical Research Institute’s COVID-19 Research Update on June 2nd, 2020 (Larry is the CEO of Texas Biomed):
“As Larry mentioned people are conducting some trials of vaccine candidates directly in human beings. Ideally under normal circumstances that's not done and for good reason these are of course not normal circumstances and some shortcuts are being taken. But what will happen is vaccine candidates will needs to demonstrate immunogenicity and efficacy in robust animal models before these vaccines can be given to large number of human beings and phase 2b and Phase 3 human trials can be realistically performed. And animal models will need to have quantifiable metrics and that's the kind of result that we've presented today. That a particular group of monkeys that are experimentally infected with this said known quantified dose of virus produces between x and y percent of ammonia at day 3 versus day 6 versus day 12. Once these models exist you will see a lot- Once these models are publicized, you will see a lot of corporate fortune 500 companies actually want to do- a lot more- want to do these vaccine trials with us and other people who would have developed these models. Some, as Dr. Turner mentioned are already doing so despite the fact that our results are not publicly available at this point of time but they know this through through other channels. But unless these data exist, it would be very difficult ethically to have these vaccines delivered to 5,000 to 50,000 individuals that is a requirement for phase 2b to phase 3 trials.” -Deepak Kaushal
It puts this November 2020 claim reported by KSAT (that’s linked on Texas Biomedical Research Institute’s website) into perspective:
Ramifications of The Falsified Research
Andrew Vernon of the CDC’s Division of TB Elimination and William Bishai of Johns Hopkins’ Center for Tuberculosis Research penned in the same journal a very strangely named article, ‘Modeling Treatment of Latent Tuberculosis: Shortening the Leap of Faith?’ where they promote the now discredited paper by Deepak Kaushal and colleagues in a very favorable light
So the importance of this trial wasn’t just to justify a treatment that the disgraced paper said “successfully eradicates persistent Mtb infection” But it seems like there is also a concerted effort trying to legitamize this type of falsifiable primate research as a predictive model of drug efficacy in humans. And it wasn’t long after when Pfizer tried to apply SNPRC’s primate models to help get their vaccine authorized.
Dr Kathrin Jansen’s Involvement with NEJM & Nature BNT162b2 Articles
Another connection between the two papers: Dr Kathrin Jansen. Pfizer’s vaccine lead during the C19 vax development & launch has received quite favorable press over the past few years. Some examples:
It seems like she was a big player in Pfizer turning their children’s 2 dose series into a 3 dose series after some terrible results from the first two shots:
This table demonstrates just how unplanned the 3rd dose was. Note the huge drop off in the numbers of participants from the BNT162b2 arm’s “Dose 1 to before Dose 2” (n=1,027) and “>= 7 Days After Dose 3” (n=277) endpoints. That’s just 27% of the starting number of participants in the 6-23 month BNT162b2 arm who even reached the final endpoint in the study. This is a huge red flag, especially as the efficacy seems to keep rising the more people drop out of the study.
Pfizer & the FDA now recommend that the 2nd BNT162b2 shot be given 3 weeks after dose #1 and the 3rd dose given “at least 8 weeks after” dose #2. Despite their timing recommendations, this regimen was never actually tested. The median wait before dose #3 was 25.3 weeks with the longest waiting 41 weeks before dose #3.
Pfizer put out a press release in Dec 2021 saying that non-inferiority was NOT met for for the 6-23 months cohort after two shots:
The study will now include evaluating a third dose of 3 µg at least two months after the second dose of the two-dose series to provide high levels of protection in this young age group… The decision to evaluate a third dose of 3 µg for children 6 months to under 5 years of age reflects the companies’ commitment to carefully select the right dose to maximize the risk-benefit profile.
And to put the nail in the coffin: the placebo group is in large part compromised. All but 8.8% of the placebo group had gone ahead and taken BNT162B2 by the June 15th, 2022 VRBPAC meeting.
Adding a third dose gave Pfizer and its contractors ONE more shot to prove BNT162b2’s effectiveness… or fake it.
Regeneron Monoclonal Antibodies Work & Constructing A Huge New Primate Research Center
In December 2021, Texas Biomedical Research Institute started building their new complex full of monkeys for Deepak Kaushal’s team to experiment on. In their article on the groundbreaking ceremony, Texas Public Radio quoted Deepak Kaushal as saying:
“We work very ethically. We are regulated very ethically and very strongly by regulatory boards that will not allow us to hurt our animals… Every step that we take in our regular lives has benefited from animal research. In neonatal medicine, in infectious disease, in cardiovascular (care), the direct work that was done here on nonhuman primates has absolutely saved lives.”
And how exactly is it “very ethical” to senselessly experiment on & kill monkeys all while falsifying and misconstruing the experimental results seemingly for your own self-interests?
The article also attributes research credits to Texas Biomed for Regeneron’s clinical trials:
“Animals at Texas Biomed were also used to study Regeneron, the monoclonal antibody therapy given to former President Trump when he had COVID-19.”
According to a press release from Nov 18, 2020 they also received $1M from the Gates Foundation to test the monoclonal antibodies for C19:
Kaushal told Texas Public Radio that the Institute’s monkey population was critical to fighting covid 19 and they quote him saying “we found that these Pfizer vaccines were very efficacious.” The question is: do you believe him?
Excellent work! The rot runs deep; it’s almost like Gates was getting his foot soldiers ready in 2019…..
The Pfizer preclinical efficacy trial publication remains to this day NOT peer reviewed; did they do this on purpose to avoid an audit of the macaque trial? As Dr. McCairn points out, every piece of research this guy has run in the last three years needs to be audited at best and tossed out at worst. We all know he will not receive any reprimand under Fauci and the NIH😡